NOCIL credit ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
−342−342−277−376−234
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−0.19×−0.19×−0.16×−0.22×−0.15×
−2.65×−3.39×−2.01×−1.93×−0.92×
33.04×33.04×46.83×87.81×164.21×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NOCIL₹147.45

NOCIL Limited

· Chemicals
₹ CrorePeersHSCLROSSARINAVINFLUORDDEVPLSTIKTATACHEMCHEMPLASTSAARTIINDJGCHEMMcap ₹2,463 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Net Debt-233.7-376.3-276.9-341.8-341.8
Net Debt/Equity-0.15-0.22-0.16-0.19-0.19
Net Debt/EBITDA-0.92-1.93-2.01-3.39-2.65
Interest Coverage (EBIT/Interest)164.2187.8146.8333.0433.04
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.